Interface
Rezultatele cautarii
Vedeti tot
  • Conecteaza-te
    Conecteaza-te
    Inscrie-te
    Căutare
    Night Mode

Director

Descoperă oameni noi, creează noi conexiuni și faceti-va noi prieteni

  • Utilizatori
  • Postari
  • Pagini
  • Grupuri
  • Events
  • Blogs
  • Offers
  • Jobs
  • Ashley Smith updated the profile picture
    2026-07-24 05:44:27 -
    0 Commentarii 0 Distribuiri 220 Views 0 previzualizare
    Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
  • Ashley Smith Crează pagină
    2026-07-24 05:46:15 -
    24
    Jul
    Plăţile
    2026 Creative Biolabs Scholarship Program
    In an effort to further support their research and higher education in the medical and science-related fields, Creative Biolabs is proud to announce the 2026 Scholarship Program, which will award $1,000 to an outstanding college student.
    1 Commentarii 0 Distribuiri 265 Views 0 previzualizare
    Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
  • Ashley Smith a adăugat un sunet Alte
    2026-07-24 05:59:32 -
    Modern Approaches to Veterinary Therapeutic Protein and Peptide Discovery: Accelerating Animal Health Innovation with High-Throughput Screening and Phage Display
    Introduction: A Shift Toward Biologics in Veterinary Drug Discovery The landscape of animal health is undergoing a significant transformation as biologic therapies gain momentum over traditional small-molecule drugs. In modern veterinary therapeutic protein and peptide discovery services, researchers are increasingly leveraging engineered proteins, peptides, and biologically derived molecules...
    0 Commentarii 0 Distribuiri 339 Views 0 previzualizare
    Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
  • Gemini Smith a adăugat un sunet Health
    2026-07-27 05:20:57 -
    Gut Pathogen Identification
      Q1: What sequencing technologies do you use for microbial profiling? A: We primarily utilize advanced next-generation sequencing (NGS) technologies, including 16S/18S/ITS amplicon sequencing and whole metagenomic sequencing, to provide a comprehensive profile of the microbiome. Q2: Can your platform distinguish between closely related bacterial strains? A: Yes. By utilizing...
    0 Commentarii 0 Distribuiri 232 Views 0 previzualizare
    Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
  • Gemini Smith a adăugat un sunet Health
    2026-07-27 05:27:18 -
    Tissue Imaging
      Q1: What types of tissue samples can be analyzed using your imaging platforms? A: We have the capability to handle a wide variety of sample types, including formalin-fixed paraffin-embedded (FFPE) sections, frozen tissue sections, and tissue microarrays (TMAs) from both human and animal models. Q2: How can this service benefit my immuno-oncology research? A: By utilizing our advanced...
    0 Commentarii 0 Distribuiri 181 Views 0 previzualizare
    Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
  • Gemini Smith a adăugat un sunet Health
    2026-07-27 05:29:47 -
    Skincare Exosome Safety Evaluation
      Q1: What specific safety aspects are evaluated for exosomes intended for cosmetic use? A: We conduct a comprehensive range of assessments, including in vitro cytotoxicity, skin irritation, ocular irritation, sensitization, and microbiological testing, to ensure that the exosomes meet strict global cosmetic safety standards. Q2: How do you test for skin irritation without using animal...
    0 Commentarii 0 Distribuiri 307 Views 0 previzualizare
    Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
  • Gemini Smith a adăugat un sunet Health
    2026-07-27 05:32:57 -
    Corneal Wound Healing Model
      Q1: What methods are used to induce corneal wounds in your animal models? A: We utilize well-established and highly reproducible methods, such as mechanical scraping of the epithelium or chemical injury (e.g., alkali burns). This allows us to accurately replicate clinical corneal defects and stromal injuries based on your specific study requirements. Q2: How do you monitor the wound...
    0 Commentarii 0 Distribuiri 310 Views 0 previzualizare
    Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
  • Gemini Smith a adăugat un sunet Health
    2026-07-27 05:36:47 -
    Surface Survival & Environmental Persistence Risk Assessment
      Q1: Why is it necessary to evaluate the environmental persistence of live biotherapeutics? A: Assessing environmental persistence is a critical regulatory requirement. It ensures that genetically modified or therapeutically enhanced live microbes do not pose unintended colonization, contamination, or biosafety risks when shed into the environment. Q2: What methodologies do you use to...
    0 Commentarii 0 Distribuiri 283 Views 0 previzualizare
    Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
  • Gemini Smith a adăugat un sunet Health
    2026-07-27 05:40:32 -
    Webinar Registration Alert: Novel Platforms for Preclinical Antibody Discovery
      Date: August 11, 2026 Time: 11:00 AM – 12:00 PM EDT Featured Guest Speaker: Dr. Ivelin Georgiev Monoclonal antibodies stand out as highly powerful preventive and therapeutic modalities against complex infectious diseases, diverse cancers, and autoimmune conditions. However, conventional antibody discovery workflows continue to hit a wall. Biopharma teams routinely...
    0 Commentarii 0 Distribuiri 297 Views 0 previzualizare
    Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
  • Gemini Smith a adăugat un sunet Health
    2026-07-27 05:44:32 -
    Electrochemical Biosensor for Disease Detection
      Q1: What types of biomarkers can be detected using your biosensor platforms? A: Our platform is highly versatile and can be customized to detect a wide range of disease biomarkers, including specific proteins, nucleic acids, metabolites, and even whole cells, offering exceptional sensitivity and rapid response times. Q2: How does your team support the development of these diagnostic...
    0 Commentarii 0 Distribuiri 290 Views 0 previzualizare
    Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
  • Afiseaza (1-10 de 75)
  • 1
  • 2
  • 3
  • 4
  • 5
  • Următor
  • »
© 2026 Interface Romaian
English Arabic French Spanish Portuguese Deutsch Turkish Dutch Italiano Russian Romaian Portuguese (Brazil) Greek
About Termeni Confidențialitate Contacteaza-ne Support Center Director